IJCOPE Journal

UGC Logo DOI / ISO Logo

International Journal of Creative and Open Research in Engineering and Management

A Peer-Reviewed, Open-Access International Journal Supporting Multidisciplinary Research, Digital Publishing Standards, DOI Registration, and Academic Indexing.
Journal Information
ISSN: 3108-1754 (Online)
Crossref DOI: Available
ISO Certification: 9001:2015
Publication Fee: 599/- INR
Compliance: UGC Journal Norms
License: CC BY 4.0
Peer Review: Double Blind
Volume 02, Issue 05

Published on: May 2026

METHOD DEVELOPMENT AND VALIDATION OF SUSTAINED RELEASE TABLETS OF PROPRANOLOL HYDROCHLORIDE

Aachal V. Ingle Ravindra H. Kale Diptee R. Bhagwat Aijaz A. Sheikh

Kailash R. Biyani

Department of Quality Assurance, Anuradha College of Pharmacy, Chikhli, Buldhana, 443201

Article Status

Plagiarism Passed Peer Reviewed Open Access

Available Documents

Abstract

The present study reports the development and comprehensive ICH Q2(R1)-compliant validation of a UV spectrophotometric analytical method for Propranolol Hydrochloride (Propranolol HCl), combined with the design and evaluation of sustained release (SR) hydrophilic matrix tablets. Propranolol HCl is a BCS Class I, non-selective β-adrenergic receptor blocker with a short biological half-life (3–6 hours) and extensive first-pass hepatic metabolism, necessitating multiple daily dosing and causing peak-to-trough plasma fluctuations. Seven SR matrix tablet formulations (F1–F7) containing 80 mg Propranolol HCl were prepared by wet granulation using varying ratios of HPMC K4M and HPMC K15M as rate-controlling polymers. The validated UV method (λmax = 220 nm, 0.1N HCl) demonstrated excellent linearity over 2–24 µg/mL (r² = 0.9999), accuracy (% recovery 99.6–100.1%), and precision (%RSD < 1%). All formulations achieved sustained drug release over 12 hours; the Korsmeyer-Peppas model best described release kinetics (r² > 0.9951), with n values of 0.48–0.78 indicating anomalous diffusion-erosion transport. Formulation F4 (HPMC K4M:K15M = 50:50) was identified as optimal, achieving 88.5% cumulative drug release at 12 hours with near-zero-order kinetics. Accelerated stability studies at 40°C/75% RH for 3 months confirmed drug content ≥ 98.9% and consistent dissolution performance. The study demonstrates that integrated analytical validation and HPMC matrix optimization provide a reproducible, clinically relevant SR platform for improved cardiovascular pharmacotherapy.

Keywords: Propranolol Hydrochloride, Sustained Release, HPMC K4M, HPMC K15M, ICH Q2(R1), UV Spectrophotometry, Matrix Tablets, Korsmeyer-Peppas, Wet Granulation.

How to Cite this Paper

Ingle, A. V., Kale, R. H., Bhagwat, D. R. & Sheikh, A. A. (2026). Method Development and Validation of Sustained Release Tablets of Propranolol Hydrochloride. International Journal of Creative and Open Research in Engineering and Management, <i>02</i>(05). https://doi.org/10.55041/ijcope.v2i5.753

Ingle, Aachal, et al.. "Method Development and Validation of Sustained Release Tablets of Propranolol Hydrochloride." International Journal of Creative and Open Research in Engineering and Management, vol. 02, no. 05, 2026, pp. . doi:https://doi.org/10.55041/ijcope.v2i5.753.

Ingle, Aachal,Ravindra Kale,Diptee Bhagwat, and Aijaz Sheikh. "Method Development and Validation of Sustained Release Tablets of Propranolol Hydrochloride." International Journal of Creative and Open Research in Engineering and Management 02, no. 05 (2026). https://doi.org/https://doi.org/10.55041/ijcope.v2i5.753.

Search & Index

References


  1. Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharmaceutical Research. 1995;12(3):413–420.

  2. Goodman LS, Gilman A. The Pharmacological Basis of Therapeutics. 13th ed. New York: McGraw-Hill; 2017. Chapter 27: Adrenergic Agonists and Antagonists.

  3. Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Advanced Drug Delivery Reviews. 2001;48(2-3):139–157.

  4. International Council for Harmonisation (ICH). ICH Q2(R1): Validation of Analytical Procedures: Text and Methodology. Geneva, Switzerland; 2005.

  5. Khan GM, Meidan VM. Drug release kinetics from tablet matrices based upon hydroxypropyl methylcellulose (HPMC): relationship between dissolution rate and polymer viscosity. Journal of Pharmacy and Pharmacology. 2007;59(4):503–509.

  6. Wankhede SB, Wadkar SS, Kolpe DM, Tajne MR. UV spectrophotometric method development and validation for estimation of propranolol hydrochloride in bulk and tablet dosage forms. Asian Journal of Pharmaceutical Analysis. 2011;1(2):35–38.

  7. Rowe RC, Sheskey PJ, Quinn ME. Handbook of Pharmaceutical Excipients. 6th ed. London: Pharmaceutical Press; 2009.

  8. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. International Journal of Pharmaceutics. 1983;15(1):25–35.

  9. Banker GS, Anderson NR. Tablets. In: Lachman L, Lieberman HA, editors. The Theory and Practice of Industrial Pharmacy. 3rd ed. Philadelphia: Lea & Febiger; 1986:293–345.

  10. Indian Pharmacopoeia Commission. Indian Pharmacopoeia. 8th ed. Ghaziabad: Ministry of Health and Family Welfare; 2018.

Ethical Compliance & Review Process

  • All submissions are screened under plagiarism detection.
  • Review follows editorial policy.
  • Authors retain copyright.
  • Peer Review Type: Double-Blind Peer Review
  • Published on: May 26 2026
CCBYNC

This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. You are free to share and adapt this work for non-commercial purposes with proper attribution.

View License
Scroll to Top